The trademark application Maglematrix was filed by Magle Chemoswed AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on July 31, 2024, and still open for oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
Research and development in the pharmaceutical and biotechnology fields
Research and development for the pharmaceutical industry
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Scientific research and development
Research and development of vaccines and medicines
Research on the subject of pharmaceuticals
Research in the field of pharmacogenetics
Testing of pharmaceuticals
Laboratory research services relating to pharmaceuticals
Technical research in the field of pharmaceutical studies
Development of pharmaceutical preparations and medicines